Laser-Assisted Wound Treatment for Selective Necrotic Tissue Removal

The patent replaces mechanical debridement instruments (scalpel, blade) with a laser system that uses optical energy to selectively remove necrotic tissue. The laser operates at specific wavelengths (e.g., 1064nm, 532nm, 308nm) that are absorbed by necrotic tissue and bacteria, causing photothermal and photochemical effects that destroy harmful tissue while sparing healthy tissue. This substitution eliminates the mechanical trauma and uncontrolled damage associated with traditional scraping methods.

The laser system applies different wavelengths and energy levels to different areas of the wound based on real-time imaging feedback. The microprocessor controls the laser to deliver specific wavelengths (e.g., 1064nm for deep penetration, 532nm for superficial tissue, 308nm for bacterial destruction) to specific zones, allowing selective destruction of necrotic tissue while preserving healthy tissue. This localized application of different energy qualities resolves the contradiction between effective debridement and tissue preservation.

The patent replaces traditional visual inspection and bacterial swabbing with a laser-based imaging and detection system. The system uses multiple wavelengths (1064nm, 532nm, 308nm) to penetrate tissue and detect underlying biological changes in real-time, including bacterial presence, tissue viability, and inflammatory markers. This optical detection method provides immediate results without the delay of laboratory processing required by traditional swabbing methods.

The patent introduces laser imaging and spectral analysis as an intermediary between visual inspection and bacterial culture. The system uses optical intermediaries (different laser wavelengths) to probe tissue properties and detect biological changes non-invasively. This intermediary detection method provides rapid information about underlying tissue conditions without requiring physical sample collection and laboratory analysis, thus reducing time loss while gaining biological information.

The laser system enables continuous debridement action in a single session rather than requiring multiple discrete sessions. The microprocessor controls the laser to systematically scan and treat the entire wound area, removing necrotic tissue continuously across the treatment zone. This continuous action achieves complete debridement in one procedure, preventing the wound from remaining open across multiple sessions and becoming chronic.

The system performs preliminary assessment using laser imaging to map the entire wound area and identify all necrotic zones before debridement begins. The microprocessor uses this preliminary information to plan the complete debridement path, ensuring all necrotic tissue is removed in one continuous process. This preliminary mapping prevents the need for multiple follow-up sessions to address remaining necrotic areas, thus preventing chronic wound development.